Clinical Trial Update: Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated hypofractionated proton beam radiation therapy in combination with paclitaxel and carboplatin for stage II-III non-small cell lung can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: COMPLETED